Asymmetric dimethylarginine Options
Myelosuppression which includes intense thrombocytopenia, neutropenia and anemia Frequently reversible; might handle by dose interruption, dose reduction, or discontinuation of therapyOutcome of clients with Persistent myeloid leukemia in lymphoid blastic period and Philadelphia chromosome-favourable acute lymphoblastic leukemia dealt with with hyp